InsidersTradesSigma
Discover the full record of transactions filed by Schott Robert J., Vice-Président Senior. Officer active across 1 companies, notably Sangamo Therapeutics, INC. In total, 2 disclosures have been recorded. The latest transaction was filed on 25 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
Robert J. Schott is Senior Vice President and Head of Development at Sangamo Therapeutics, Inc. In this role, he oversees the product development and research initiatives of the company, which is active in the biopharmaceutical sector. His technical expertise is essential for innovation and growth.